[
  {
    "ts": null,
    "headline": "J.P. Morgan Raises PT on Thermo Fisher Scientific (TMO) Keeps an Overweight Rating",
    "summary": "​Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the Best Forever Stocks to Invest In Now. On October 9, J.P. Morgan analyst Casey Woodring raised the firm’s price target on Thermo Fisher Scientific Inc. (NYSE:TMO) from $600 to $650, while keeping an Overweight rating on the stock. ​The rating comes ahead of the company’s fiscal […]",
    "url": "https://finnhub.io/api/news?id=03678953cd7f40a67b7f353f883d889b63e044cb6cbd862f64e04df3da0b6e87",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760646898,
      "headline": "J.P. Morgan Raises PT on Thermo Fisher Scientific (TMO) Keeps an Overweight Rating",
      "id": 137121890,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "​Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the Best Forever Stocks to Invest In Now. On October 9, J.P. Morgan analyst Casey Woodring raised the firm’s price target on Thermo Fisher Scientific Inc. (NYSE:TMO) from $600 to $650, while keeping an Overweight rating on the stock. ​The rating comes ahead of the company’s fiscal […]",
      "url": "https://finnhub.io/api/news?id=03678953cd7f40a67b7f353f883d889b63e044cb6cbd862f64e04df3da0b6e87"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Advance Thursday Afternoon",
    "summary": "Health care stocks rose Thursday afternoon, with the NYSE Health Care Index adding 0.3% and the Heal",
    "url": "https://finnhub.io/api/news?id=4a2a9a2c0b0006057ab0336f01ed4e3745c0e7d849de2314bf4bf3ea6e6512cc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760637097,
      "headline": "Sector Update: Health Care Stocks Advance Thursday Afternoon",
      "id": 137121891,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Health care stocks rose Thursday afternoon, with the NYSE Health Care Index adding 0.3% and the Heal",
      "url": "https://finnhub.io/api/news?id=4a2a9a2c0b0006057ab0336f01ed4e3745c0e7d849de2314bf4bf3ea6e6512cc"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market",
    "url": "https://finnhub.io/api/news?id=26c5d609712793909cd067fef3686e8642e563d806c144f7bc22339d9cce41fb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760632440,
      "headline": "Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market",
      "id": 137137829,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market",
      "url": "https://finnhub.io/api/news?id=26c5d609712793909cd067fef3686e8642e563d806c144f7bc22339d9cce41fb"
    }
  },
  {
    "ts": null,
    "headline": "TMO to Report Q3 Earnings: Life Science Solutions Segment in Focus",
    "summary": "Thermo Fisher's Q3 results on Oct. 22 are set to spotlight gains from new launches and acquisitions across key growth segments.",
    "url": "https://finnhub.io/api/news?id=644f02a580ed86af493b2efd2c493169394daa8de3a2d54f6cc922fd8da78499",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760618940,
      "headline": "TMO to Report Q3 Earnings: Life Science Solutions Segment in Focus",
      "id": 137106257,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher's Q3 results on Oct. 22 are set to spotlight gains from new launches and acquisitions across key growth segments.",
      "url": "https://finnhub.io/api/news?id=644f02a580ed86af493b2efd2c493169394daa8de3a2d54f6cc922fd8da78499"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI",
    "summary": "WALTHAM, Mass., October 16, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines to patients faster and more cost effectively.",
    "url": "https://finnhub.io/api/news?id=4ad03417de4bd283e985a44658677dfc22317470c5729428b78569ab14852889",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760616000,
      "headline": "Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI",
      "id": 137104542,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., October 16, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines to patients faster and more cost effectively.",
      "url": "https://finnhub.io/api/news?id=4ad03417de4bd283e985a44658677dfc22317470c5729428b78569ab14852889"
    }
  },
  {
    "ts": null,
    "headline": "Residual DNA Testing Research Report 2025-2035: Adoption of NGS and Real-Time PCR Technologies and Growing Demand for Personalized Medicine Bolster Market Growth",
    "summary": "Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures biopharmaceuticals like vaccines are contaminant-free, as required by FDA and EMA. Growing demand in biopharma, powered by the rise of gene therapies and personalized medicine, drives market expansion. Key players like Thermo Fisher and Roche innovate with technologies like NGS. Despite challenges like high costs and ethical concerns,",
    "url": "https://finnhub.io/api/news?id=932d57fb57f95e2c29617a40f657a25a06541c1716ebe99da13025f256607d99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760613600,
      "headline": "Residual DNA Testing Research Report 2025-2035: Adoption of NGS and Real-Time PCR Technologies and Growing Demand for Personalized Medicine Bolster Market Growth",
      "id": 137104543,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures biopharmaceuticals like vaccines are contaminant-free, as required by FDA and EMA. Growing demand in biopharma, powered by the rise of gene therapies and personalized medicine, drives market expansion. Key players like Thermo Fisher and Roche innovate with technologies like NGS. Despite challenges like high costs and ethical concerns,",
      "url": "https://finnhub.io/api/news?id=932d57fb57f95e2c29617a40f657a25a06541c1716ebe99da13025f256607d99"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare CMO Analysis Report 2025: Market to Reach $291.25 Billion by 2029, Driven by Catalent, Samsung Biologics, and Thermo Fisher Scientific",
    "summary": "The global healthcare CMO market, valued at $145.83 billion in 2023, is expected to surge to $291.25 billion by 2029, driven by increased demand for pharmaceutical and biopharmaceutical products due to rising chronic diseases and an aging population. Pharmaceutical outsourcing to CMOs helps companies cut costs and leverage advanced manufacturing technologies. Key trends include AI adoption, personalized medicine, and sustainable practices. The market is projected to grow at a CAGR of 12.22% from",
    "url": "https://finnhub.io/api/news?id=b1c735576b51e9f434fa22ae0484d2bcdfc6aefcdb84e49928411bf170de443c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760602080,
      "headline": "Healthcare CMO Analysis Report 2025: Market to Reach $291.25 Billion by 2029, Driven by Catalent, Samsung Biologics, and Thermo Fisher Scientific",
      "id": 137104544,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The global healthcare CMO market, valued at $145.83 billion in 2023, is expected to surge to $291.25 billion by 2029, driven by increased demand for pharmaceutical and biopharmaceutical products due to rising chronic diseases and an aging population. Pharmaceutical outsourcing to CMOs helps companies cut costs and leverage advanced manufacturing technologies. Key trends include AI adoption, personalized medicine, and sustainable practices. The market is projected to grow at a CAGR of 12.22% from",
      "url": "https://finnhub.io/api/news?id=b1c735576b51e9f434fa22ae0484d2bcdfc6aefcdb84e49928411bf170de443c"
    }
  },
  {
    "ts": null,
    "headline": "From Magnificent To Stretched: Rethink U.S. Equity Allocations",
    "summary": "A small number of companies dominate US equity market size and earnings, making investors reliant on the fortunes of a select few.",
    "url": "https://finnhub.io/api/news?id=bcb384d44917522deadb7813a6f0f1fd74ab1db745201614fd17e6bcd5b5a001",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760594640,
      "headline": "From Magnificent To Stretched: Rethink U.S. Equity Allocations",
      "id": 137103600,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2007398242/image_2007398242.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "A small number of companies dominate US equity market size and earnings, making investors reliant on the fortunes of a select few.",
      "url": "https://finnhub.io/api/news?id=bcb384d44917522deadb7813a6f0f1fd74ab1db745201614fd17e6bcd5b5a001"
    }
  }
]